Posted inBiotechnology
Transforming Cellulose: Innovations and Applications Unveiled
Cellulose, one of nature’s most abundant biopolymers, serves an essential role in the structural integrity of plant cell walls. Its…
Posted inBiotechnology
Nurses’ Insights and Practices on Sarcopenia Explored
In a groundbreaking descriptive study, researchers led by M.H. Taani, H. Skuble, and C. Antwi-Boasiako have undertaken a significant evaluation…
Posted inBiotechnology
MetaVia weighs in with 9% loss as dual agonist enters the obesity ring
MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people…
Posted inBiotechnology
Major Music Events Linked to Subclinical Hearing Damage
In a groundbreaking study published in Scientific Reports, researchers have unveiled startling evidence concerning the auditory implications of large-scale music…
Posted inMedical Technology
Abbott launches AI-based Libre Assist, its new in-app feature for meal planning
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s…
Posted inBiotechnology
Incretin Modulation Revolutionizes Diabetes, Heart, and Kidney Health
Recent advancements in diabetes therapy have taken a significant turn as researchers delve into incretin modulation, revealing its profound potential…
Posted inBiotechnology
Unveiling Maclura Tricuspidata’s Complete Mitochondrial Genome
In a groundbreaking study, researchers have unveiled the complete mitochondrial genome of Maclura tricuspidata, a plant species common to East…
Posted inBiotechnology
AI Predicts Ice Hockey Impact with Strain Analysis
In recent years, the intersection of sports and technology has opened doors to innovative methodologies that enhance performance and safety.…
Posted inBiotechnology
Zenas’ stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit
A phase 3 study of Zenas BioPharma's autoimmune disease candidate has hit its primary endpoint. But, with the result falling short…
Posted inBiotechnology
Aktis Oncology aims for $209M windfall from 1st biotech IPO of 2026
Aktis Oncology is aiming to bring in $182 million—or more—from what looks set to be the first biotech IPO of…